In The Know: US dermatologists rate psoriasis therapies on satisfaction

When asked to rate therapies to treat patients with moderate-to-severe psoriasis, a sample of 100 US dermatologists ranked Novartis’ Cosentyx in first place in terms of overall satisfaction with the brand (see Table 1).

Table 1: Psoriasis therapies ranked by US dermatologists for brand satisfaction

Rank Brand Name Generic Name Company
1 Cosentyx secukinumab Novartis
2 Taltz ixekizumab Eli Lilly
3 Humira adalimumab AbbVie
4 Stelara ustekinumab Janssen Biotech
5 Tremfya guselkumab Janssen Biotech
6 Otezla apremilast Celgene
7 Enbrel etanercept Amgen
8 Siliq brodalumab Valeant
Source: FirstWord, NPS+ (US) -- Psoriasis (2018)

Based on the Net Promoter Score (NPS) system, of the eight brands featured in the survey, five received positive scores, but with a gap of 99 ranking points between first and last place, clearly some brands have some catching up to do.

Other brand satisfaction tables available

FirstWord has conducted similar research in 17 competitive disease areas in the US and EU. Contact us to learn more.


Click here to discuss this research with a FirstWord consultant.

To read more Sponsored Story articles, click here.

Reference Articles